Functional Technologies (TSXV:FEB.H) ROCE % : -359.37% (As of Aug. 2012)

View and export this data going back to . Start your Free Trial

What is Functional Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Functional Technologies's annualized ROCE % for the quarter that ended in Aug. 2012 was -359.37%.

Functional Technologies ROCE % Historical Data

The historical data trend for Functional Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Functional Technologies ROCE % Chart

Functional Technologies Annual Data

Trend

Aug03

Aug04

Aug05

Aug06

Aug07

Aug08

Aug09

Aug10

Aug11

Aug12

ROCE %

Get a 7-Day Free Trial

-89.13

-75.12

-57.32

-56.64

-359.37

Functional Technologies Semi-Annual Data
	Aug01	Aug02	Aug03	Aug04	Aug05	Aug06	Aug07	Aug08	Aug09	Aug10	Aug11	Aug12
ROCE %	Get a 7-Day Free Trial							-89.13	-75.12	-57.32	-56.64	-359.37

Functional Technologies ROCE % Calculation

Functional Technologies's annualized ROCE % for the fiscal year that ended in Aug. 2012 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Aug. 2012 )		(A: Aug. 2011 )		(A: Aug. 2012 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Aug. 2012 )		(A: Aug. 2011 )		(A: Aug. 2012 )
	=	-12.481	/	( ( (11 - 1.221)	+	(2.733 - 5.566) )	/ 2 )
	=	-12.481	/	( (9.779	+	-2.833)	/ 2 )
	=	-12.481	/	3.473
	=	-359.37 %

Functional Technologies's ROCE % of for the quarter that ended in Aug. 2012 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Aug. 2012 )		(Q: Aug. 2011 )		(Q: Aug. 2012 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Aug. 2012 )		(Q: Aug. 2011 )		(Q: Aug. 2012 )
	=	-12.481	/	( ( (11 - 1.221)	+	(2.733 - 5.566) )	/ 2 )
	=	-12.481	/	( ( 9.779	+	-2.833 )	/ 2 )
	=	-12.481	/	3.473
	=	-359.37 %

(1) Note: The EBIT data used here is one times the annual (Aug. 2012) EBIT data.

Functional Technologies (TSXV:FEB.H) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Functional Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Functional Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Functional Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Functional Technologies Corp (TSXV:FEB.H) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.firstventuretech.com

Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.

Functional Technologies Headlines

No Headlines